logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Polyomaviruses And Human Diseases 1st Edition Nasimul Ahsan Md

  • SKU: BELL-2164690
Polyomaviruses And Human Diseases 1st Edition Nasimul Ahsan Md
$ 31.00 $ 45.00 (-31%)

4.4

52 reviews

Polyomaviruses And Human Diseases 1st Edition Nasimul Ahsan Md instant download after payment.

Publisher: Springer-Verlag New York
File Extension: PDF
File size: 25.92 MB
Pages: 360
Author: Nasimul Ahsan M.D., FACP, Keerti V. Shah M.D., Dr.P.H. (auth.), Nasimul Ahsan M.D., FACP (eds.)
ISBN: 9780387292335
Language: English
Year: 2006
Edition: 1

Product desciption

Polyomaviruses And Human Diseases 1st Edition Nasimul Ahsan Md by Nasimul Ahsan M.d., Facp, Keerti V. Shah M.d., Dr.p.h. (auth.), Nasimul Ahsan M.d., Facp (eds.) 9780387292335 instant download after payment.

Science never solves apr oblem without creating ten more Geor ge Bernard Shaw How prophetic the above words prove to be when applied to the advances of 20th century medicine. Prior to Banting and Best, chnicians were unaware of the ravages of diabetes, patients simply wasted away and died. Following the purifica­ tion of insulin, clinicians now had to deal with diabetic retinopathy, diabetic neph­ ropathy and all the other complications of long-term diabetes. A little over 50 years ago, the first successful human kidney transplant was performed in Boston. The first 30 years of the experience had successes when compared to the alternative but were a constant struggle to get even 50% of the grafts from deceased donors to survive more than a year. However, the science continued to advance knowledge of the immune response. With this came more and increasingly powerful tools for the clinician. Suddenly, success rates of 80-90% at one year were attainable. With this success came new problems, new complications and clinicians now had to worry about the long-term consequences of their therapy as patients were surviving with functional grafts for extended periods. A particular infectious complication evolved with the application of ever more powerful immunosuppressant drugs. Astute clinicians noted that occasionally cellular rejections seemed to get worse with steroids. Despite their best efforts and the use of powerful drugs, patients lost their grafts to overwhelming interstitial infiltrates not seen before.

Related Products